TortsProf Blog

Editor: Christopher J. Robinette
Southwestern Law School

Thursday, July 31, 2008

Plaintiff's Verdict in First Mirapex Trial; Second One Already Going

So reports Pharmalot.  No damages set as yet.


July 31, 2008 in Products Liability | Permalink | Comments (16) | TrackBack (0)

Torts in Missouri Politics

For the most part, certainly at the national level, tort issues have not been central to campaigning, at least so far this year. But this ad has been released in a Missouri race, attacking a Republican candidate for the U.S. House for her efforts to prevent damage caps when in the state Senate:

(The story describes it as a "Wev ad" -- I assume that's a typo and that it's a Web-only ad. It's pretty long -- 1:24 -- so I doubt it's actually aired on TV.)


July 31, 2008 in Legislation, Reforms, & Political News | Permalink | Comments (0) | TrackBack (0)

Schuck on New Zealand Accident Law

Peter Schuck (Yale/NYU) has posted Tort Reform, Kiwi-Style on SSRN.  Here is the abstract:

American legal scholars and social scientists have long been intrigued by New Zealand's accident compensation system, which essentially abolished common law tort almost 40 years ago. This paper, prepared for a conference sponsored by the Brookings Institution and Common Good, provides an up-to-date account of the New Zealand system, with a focus on its treatment of two types of claims - for medical injuries and emotional distress - that raise particularly vexing boundary problems for the system. It then discusses a number of lessons that U.S. policymakers and scholars can draw from the New Zealand experience.

(Via Solum/Legal Theory Blog)


July 31, 2008 in Scholarship | Permalink | Comments (0) | TrackBack (1)

Wednesday, July 30, 2008

Six Flags Case Muddles Along

It's been a year since Katie Lasitter's feet were severed by the Superman: Tower of Power ride at Six Flags Kentucky Kingdom, and it astonishes me that the case is still going even now, especially after the various revelations since then (like, oh, this one).  But discovery continues apace and now there's a trial date -- in 2010.  There are 77 depositions yet to take (roughly evenly divided between the parties) and, intriguingly, Six Flags's counsel states that "Six Flags may also seek to add a defendant to the case."  While he declined to identify that defendant, it seems like the manufacturer might come to mind.


July 30, 2008 in Current Affairs | Permalink | Comments (0) | TrackBack (1)

CPSC Reform Bill Moves Forward

A conference committee has reached an agreement on a bill to reform the Consumer Product Safety Commission (CPSC).    The House passed a reform bill in December 2007, and the Senate passed its own measure in March 2008.  Differences between the two bills, however, forced a long conference period.  A copy of the Conference Report is available here [pdf]. 

Consumer Reports highlights a few key features of the Consumer Product Safety Improvement Act of 2008 (H.R. 4040) including "the toy safety standard, for which compliance has been voluntary, will become mandatory," and "[t]oys and other children’s products will be required to be tested for safety by independent laboratories before they are sold."


July 30, 2008 in Legislation, Reforms, & Political News | Permalink | Comments (0) | TrackBack (0)

Mandatory Country of Origin Labeling

Yesterday, U.S. Department of Agriculture issued a new rule requiring meat, fruit, vegetable and nut retailers to notify  customers of the food's country of origin.   The rule takes effect September 30, 2008. 


July 30, 2008 in Legislation, Reforms, & Political News | Permalink | Comments (0) | TrackBack (0)

Tuesday, July 29, 2008

The Personal Injury Roundup is Dead! Long Live the Personal Injury Roundup!

Most of our readers probably know about the personal injury roundup -- it started and then stopped with Eric Turkewitz, then went to Brooks Schuelke, who announced last week its demise.

Well, we're going to take a shot at it now.  With three of us, we figure we can rotate and it'll work out.  Or not.  We'll see.

So: send us tips -- our e-mail addresses are over there on the left -- and we'll start with our first this coming Friday!

Thanks to Eric and Brooks for setting the bar high.  We hope we can keep up.


July 29, 2008 | Permalink | Comments (1) | TrackBack (1)

Updated: List of Pharma-Free Experts Published

A few months back, Shannon Brownlee and Jeanne Lenzer wrote on Slate about potential conflicts of interest, addressing doctors who had received funds from pharma talking about SSRIs on public radio. They stated that they'd created a list of pharma-free experts for journalists, but declined to share it with Ted Frank at AEI. They also declined at the time to share it with me, but noted that they intended to post it publicly at some point, and sure enough, it's now up here at their site,

Glancing through, I recognize one or two names from having done work for plaintiffs (e.g., Psaty), but not as many as I would have predicted. Update: Beck & Herrmann are collecting via the comments fields who all on the list has been a paid plaintiffs' expert.


Update: Whoops! Almost forgot my own disclosure. I have done some consulting for pharma companies. I have no current pharma clients, but have in this calendar year.

July 29, 2008 in Experts & Science | Permalink | Comments (5) | TrackBack (1)

California Supreme Court Accepts Case On Public Use of Private Lawyers

The California Supreme Court has accepted review in County of Santa Clara v. Superior Court (S163681).  The question presented is whether a public entity may retain private counsel to prosecute a public nuisance abatement action under a contingency fee agreement.    In the lower court's decision, the California Court of Appeal approved the practice. 

UCL Practitioner and Point of Law both have analysis of the appellate court's decision.


July 29, 2008 in Legislation, Reforms, & Political News | Permalink | Comments (0) | TrackBack (0)

No Punitive Damages for NY Smokers

In a decision last week, the New York Appellate Division (First Dept.) held that individual punitive damages claims by NY smokers are barred by the doctrine of res judicata.   The court reasoned that the 1998 Master Settlement Agreement with the tobacco companies extinguished claims for punitive damages:

[A] claim by a private attorney general to vindicate what is an essentially public interest in imposing a punitive sanction cannot lie where, as here, that interest has been previously and appropriately represented by the State Attorney General in an action addressed, on behalf of all of the people of the State, including plaintiffs and the decedent, to the identical misconduct.

The court rejected the idea that punitive damages serve any private purposes: 

[P]unitive damages claims are quintessentially and exclusively public in their ultimate orientation and purpose, and in that respect peculiarly appropriate for prosecution by the Attorney General in parens patriae. Such claims do not, even when asserted in the context of a personal injury action, essentially relate to individual injury. They are allowed, "not to compensate the injured party but rather to punish the tortfeasor and to deter th[e] wrongdoer and others similarly situated from indulging in the same conduct in the future". Indeed, the courts of this State have been so adamant that punitive damages are "a social exemplary remedy,' [and] not a private compensatory remedy," that the imposition of such damages for private purposes has been held to violate public policy.

A claim for punitive damages may, of course, be rooted in personal injury, but for such a claim to succeed the injury must be shown to be emblematic of much more than individually sustained wrong. It must be shown to reflect pervasive and grave misconduct affecting the public generally, to, in a sense, merge with a serious public grievance, and thus merit punitive, indeed quasi-criminal sanction by the State. As Chief Judge Breitel observed in Garrity, punitive damages are in their true aspect a prerogative reserved to the State for the accomplishment of social purposes, and it is thus fitting that those who pursue such damages in the context of private actions should be viewed as acting in the State's behalf, as "private attorneys general." (internal citations omitted).

(My thanks to Meredith Miller for alerting me to the opinion). 


July 29, 2008 in Damages, Products Liability | Permalink | Comments (0) | TrackBack (0)

Monday, July 28, 2008

CJD: "Racial prejudice lurks behind the 'tort reform' movement"

That's the conclusion of an article in the Washington University Journal of Law & Policy (with a 2007 citation date, but the press release is today). The article is available here [PDF], written by the president of and an attorney at the Center for Justice & Democracy. The conclusion:

Minorities are frequently forced to bear a disproportionately large share of this country’s health and safety problems. Whether it is inferior medical care, infringed civil rights, environmental pollution or any number of other indignities and injuries that juries are asked to evaluate every day, our civil justice system provides an essential tool to combat injustice in America.

Tort reform has a troubling and disproportionate effect on racial and ethnic minorities who have been injured and seek justice through the civil courts. In some cases, Congress has gone out of its way to exacerbate these effects. The civil justice system has been a beacon of civil rights over the last half of the twentieth century and for that it deserves to be celebrated, not stripped of its power.


July 28, 2008 in Legislation, Reforms, & Political News, Scholarship | Permalink | Comments (1) | TrackBack (0)

Zyprexa Protective Order Piece Published

It took a bit longer than I expected, but my article, When the Bell Can't be Unrung: Document Leaks and Protective Orders in Mass Tort Litigation, is now out in The Review of Litigation (the article is not online there, but available via Lexis and Westlaw). Its citation is 27 Rev. Litig. 565. It will be reprinted later this year by the American Enterprise Institute, and we're working on a panel discussion addressing it.

The piece is based in part on a number of posts here addressing the document leak in the Zyprexa litigation, starting with this one. You can see other posts here.


July 28, 2008 in Documents, Experts & Science, Products Liability | Permalink | Comments (2) | TrackBack (0)

Mirapex Bellwether Trials Starting

The Minneapolis Star Tribune reports that the first of three bellwether trials have started in Minneapolis (in front of my judge), testing the case for the link between Parkinson's/restless leg syndrome drug Mirapex and compulsive gambling. The first cases are being tried by veteran trial lawyer (and former U.S. Senate candidate) Mike Ciresi; the Strib reports that there are about 200 suits filed.

I first posted about Mirapex about two years ago.

A recent story about another suit involving the drug provides a typical fact pattern and also notes a recent study that "found that people taking dopamine agonist drugs—Mirapex is in this class of drugs—which help control movement problems, were two-to-three times more likely to have at least one of four common impulse control disorders: Pathological gambling, compulsive buying, compulsive sexual behavior, and binge eating."


July 28, 2008 in Products Liability | Permalink | Comments (0) | TrackBack (0)

Saturday, July 26, 2008

A.M. Best: Med Mal Leads Captives' Premium Decline

From the Wall Street Journal's Market Watch:

OLDWICK, N.J., Jul 25, 2008 (BUSINESS WIRE) -- Falling medical malpractice premiums led to a 15% drop in net premiums written between 2006 and 2007 for a composite of captive insurance companies, but captives overall benefited from favorable underwriting trends, according to a new A.M. Best Co.'s special report in BestWeek U.S./Canada.
The full column is here.

July 26, 2008 | Permalink | Comments (0) | TrackBack (0)

Friday, July 25, 2008

Granite Countertops: The Next Wave of Tort Suits?

Sometimes the first sentence of an article says it all:

Plaintiffs lawyers are advertising on the Internet for clients whose granite countertops are emitting high levels of radon.

If necessary, the rest of the story from the ABA Journal is here.


July 25, 2008 in Current Affairs | Permalink | Comments (0) | TrackBack (0)

Massachusetts Accepts Loss of Chance Doctrine

On Wednesday, the Massachusetts Supreme Judicial Court acknowledged, for the first time, that the loss of chance doctrine was good law in that jurisdiction:

"Where a physician's negligence reduces or eliminates the patient's prospects for achieving a more favorable medical outcome, the physician has harmed the patient and is liable for damages," the court said in a decision written by Chief Justice Margaret Marshall.

Damages will be awarded proportionate to the diminished survival rate caused by the physician's negligence.  The full story is here.


July 25, 2008 in Current Affairs | Permalink | Comments (1) | TrackBack (0)

Thursday, July 24, 2008

Sharkey on Preemption, Part II

The Northwestern University Law Review's Colloquy has just uploaded part II of Cathy Sharkey's essay What Riegel Portends for FDA Preemption of State Law Products Liability Claims.


July 24, 2008 in Scholarship | Permalink | Comments (1) | TrackBack (0)

Hilden on Defamation Online

Julie Hilden's column this week on Writ discusses some advantages held by online news sources in the context of defamation litigation (focused largely on the shallow pockets of bloggers) and suggests some ways that bigger players might achieve similar results.


July 24, 2008 in Current Affairs | Permalink | Comments (0) | TrackBack (0)

Monday, July 21, 2008

Sharkey on Preemption

This morning, the Northwestern University Law Review's Colloquy posted part I of Cathy Sharkey's What Riegel Portends for FDA Preemption of State Law Products Liability Claims.  Part II will be available on Thursday.


July 21, 2008 in Scholarship | Permalink | Comments (0) | TrackBack (0)

New FDA Dissent Website

A very interesting new site,, has been launched, purportedly by current and former FDA employees concerned about the operation of the FDA, in particular in drug review, and in particular about directives from "upper management."

The domain is registered to James Dickinson, who operates, but he states he just allowed his name to be used for registration. (Query whether that's consistent with ICANN's policy requiring accurate contact information -- and also observe that the group could, for nine bucks, registered the domain anonymously through the registrar they're already with, But that's all a little beside the point, I suppose.)


July 21, 2008 in Legislation, Reforms, & Political News | Permalink | Comments (0) | TrackBack (0)